Bio-Techne Corp. buy UBS Group AG
Start price
06.11.25
/
50%
€50.50
Target price
06.11.26
€60.82
Performance (%)
0.32%
Price
18.02.26
€50.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG for Bio-Techne Corp. is nearly unchanged. Dividends of €0.16 are taken into consideration when calculating the performance. This prediction currently runs until 06.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Techne Corp. | -7.339% | -7.339% |
| iShares Core DAX® | 1,43 % | 1,58 % |
| iShares Nasdaq 100 | 1,89 % | -2,28 % |
| iShares Nikkei 225® | -1,62 % | 7,95 % |
| iShares S&P 500 | 1,92 % | -0,28 % |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Techne Corp. diskutieren
Bio-Techne (NASDAQ:TECH) had its price target raised by analysts at UBS Group AG from $65.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for TECH provided by MarketBeat